SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : IPIC
IPIC 0.0001000+899.9%Aug 15 3:35 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Todd D. Wiener who wrote (564)8/14/1997 8:48:00 AM
From: Graham Marshman   of 1359
 
Actually, re-reading their Q2 release, they do claim that first half revenues of Redux are increased, NOT the quarters revenue. Looks like it's running flattish at about the $200M rate with a slighly better second half.

Based on AHP Q1, IPIC revenue = 30% of AHP sales. Discounting cost of goods ends with an IPIC contribution of 12.25% of AHP sales. This includes licensing & sale of capsules.

Could increase if cumulative $50M was crossed in Q1, as is possible.

Graham
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News